Reported Earnings • Aug 05
First quarter 2027 earnings released: EPS: ₹0.34 (vs ₹0.06 in 1Q 2026) First quarter 2027 results: EPS: ₹0.34 (up from ₹0.06 in 1Q 2026). Revenue: ₹220.4m (up 34% from 1Q 2026). Net income: ₹5.05m (up 445% from 1Q 2026). Profit margin: 2.3% (up from 0.6% in 1Q 2026). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 34% per year, which means it has not declined as severely as earnings. Announcement • Jul 28
Chemcrux Enterprises Limited to Report Q1, 2027 Results on Aug 04, 2026 Chemcrux Enterprises Limited announced that they will report Q1, 2027 results on Aug 04, 2026 Reported Earnings • May 16
Full year 2026 earnings released: EPS: ₹2.52 (vs ₹2.64 in FY 2025) Full year 2026 results: EPS: ₹2.52 (down from ₹2.64 in FY 2025). Revenue: ₹826.7m (up 17% from FY 2025). Net income: ₹37.3m (down 4.7% from FY 2025). Profit margin: 4.5% (down from 5.5% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 36% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₹83.07, the stock trades at a trailing P/E ratio of 59x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 78% over the past three years. New Risk • Apr 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 21% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.8% average weekly change). Profit margins are more than 30% lower than last year (2.9% net profit margin). Market cap is less than US$100m (₹1.25b market cap, or US$13.4m). Valuation Update With 7 Day Price Move • Mar 30
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₹65.80, the stock trades at a trailing P/E ratio of 46.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 77% over the past three years. Reported Earnings • Feb 06
Third quarter 2026 earnings released: EPS: ₹1.06 (vs ₹0.89 in 3Q 2025) Third quarter 2026 results: EPS: ₹1.06 (up from ₹0.89 in 3Q 2025). Revenue: ₹227.2m (up 17% from 3Q 2025). Net income: ₹15.8m (up 19% from 3Q 2025). Profit margin: 6.9% (up from 6.8% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings. Reported Earnings • Nov 07
Second quarter 2026 earnings released: EPS: ₹0.14 (vs ₹0.77 in 2Q 2025) Second quarter 2026 results: EPS: ₹0.14 (down from ₹0.77 in 2Q 2025). Revenue: ₹183.7m (up 3.5% from 2Q 2025). Net income: ₹2.13m (down 81% from 2Q 2025). Profit margin: 1.2% (down from 6.5% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings. New Risk • Oct 31
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 12% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.9% average weekly change). Profit margins are more than 30% lower than last year (4.0% net profit margin). Market cap is less than US$100m (₹2.10b market cap, or US$23.7m). Valuation Update With 7 Day Price Move • Oct 30
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹132, the stock trades at a trailing P/E ratio of 70.7x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 64% over the past three years. Declared Dividend • Aug 31
Dividend of ₹1.00 announced Dividend of ₹1.00 is the same as last year. Ex-date: 17th September 2025 Payment date: 24th October 2025 Dividend yield will be 0.9%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (38% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 36% per year over the past 8 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 58% to shift the payout ratio to a potentially unsustainable range, which is more than the 24% EPS decline seen over the last 5 years. Reported Earnings • Aug 07
First quarter 2026 earnings released: EPS: ₹0.06 (vs ₹0.84 in 1Q 2025) First quarter 2026 results: EPS: ₹0.06 (down from ₹0.84 in 1Q 2025). Revenue: ₹165.0m (down 3.5% from 1Q 2025). Net income: ₹927.0k (down 93% from 1Q 2025). Profit margin: 0.6% (down from 7.2% in 1Q 2025). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings. Announcement • Aug 02
Chemcrux Enterprises Limited to Report Q1, 2026 Results on Aug 06, 2025 Chemcrux Enterprises Limited announced that they will report Q1, 2026 results on Aug 06, 2025 Announcement • May 21
Chemcrux Enterprises Limited (BSE:540395) acquired remaining 50% stake in Kalichem Private Limited from Kalintis Healthcare Pvt. Ltd. Chemcrux Enterprises Limited (BSE:540395) acquired remaining 50% stake in Kalichem Private Limited from Kalintis Healthcare Pvt. Ltd. on February 27, 2025.
Chemcrux Enterprises Limited (BSE:540395) completed the acquisition of remaining 50% stake in Kalichem Private Limited from Kalintis Healthcare Pvt. Ltd. on February 27, 2025. Reported Earnings • May 21
Full year 2025 earnings released: EPS: ₹2.64 (vs ₹5.70 in FY 2024) Full year 2025 results: EPS: ₹2.64 (down from ₹5.70 in FY 2024). Revenue: ₹715.0m (down 8.9% from FY 2024). Net income: ₹39.1m (down 54% from FY 2024). Profit margin: 5.5% (down from 11% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Announcement • May 13
Chemcrux Enterprises Limited to Report Q4, 2025 Results on May 20, 2025 Chemcrux Enterprises Limited announced that they will report Q4, 2025 results on May 20, 2025 Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 39% After last week's 39% share price gain to ₹143, the stock trades at a trailing P/E ratio of 37.8x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 14% over the past three years. New Risk • Apr 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.4% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (124% cash payout ratio). Share price has been volatile over the past 3 months (8.8% average weekly change). Profit margins are more than 30% lower than last year (7.7% net profit margin). Market cap is less than US$100m (₹1.77b market cap, or US$20.7m). Announcement • Mar 21
Chemcrux Enterprises Limited Announces Regularisation of Additional Director (Non-Executive, Independent), Mr. Rohit Kothari as A Non-Executive Independent Director and Chairperson of Audit Committee and Member of Nomination and Remuneration Committee Chemcrux Enterprises Limited announced regularisation of Additional Director (Non-Executive, Independent), Mr. Rohit Kothari, by appointing him as a Non-Executive Independent Director. Effective Date of Appointment of 12 February 2025. Appointment as an Independent Director for 5 years with effective from 12 February 2025 till 11 February 2030 by shareholders through Postal Ballot. Not liable to retire by rotation. Qualifications: Chartered Accountant (CA); Bachelor of Commerce (B. Com) from The Maharaja Sayajirao University of Baroda (M.S. University). In Practice since 1986. Presently a Partner with M/s. Mukund & Rohit, Chartered Accountants, Vadodara. Practices in the areas of Risk Advisory and Management Consulting. Experience: More than 35 years. Directorship in other companies (excluding this listed entity): 1. Rohman Advisory Holdings Private Limited; 2. Anwesha Foundation; 3. M&R Advisory Services Private Limited. Membership of committees in public limited companies including this listed entity: Chemcrux Enterprises Limited (with effective from 12 February 2025): Audit Committee - Chairperson and Nomination and Remuneration Committee - Member. New Risk • Feb 12
New major risk - Revenue and earnings growth Earnings have declined by 3.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.4% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (124% cash payout ratio). Profit margins are more than 30% lower than last year (7.7% net profit margin). Market cap is less than US$100m (₹2.21b market cap, or US$25.4m). Announcement • Feb 11
Chemcrux Enterprises Limited Announces Resignation of Mukund Prahlad Bakshi as Independent Director Chemcrux Enterprises Limited at its board of directors meeting held on February 11, 2025, announced the resignation of Mr. Mukund Prahlad Bakshi as an Independent Director of the Company due health reasons and the same has been accepted by the Board with effect from close of business hours of 11 February 2025. Announcement • Feb 04
Chemcrux Enterprises Limited to Report Q3, 2025 Results on Feb 11, 2025 Chemcrux Enterprises Limited announced that they will report Q3, 2025 results at 9:15 AM, Indian Standard Time on Feb 11, 2025 New Risk • Jan 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (124% cash payout ratio). Share price has been volatile over the past 3 months (7.5% average weekly change). Market cap is less than US$100m (₹2.24b market cap, or US$26.0m). Valuation Update With 7 Day Price Move • Jan 22
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹181, the stock trades at a trailing P/E ratio of 37x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 14% over the past three years. Reported Earnings • Nov 12
Second quarter 2025 earnings released: EPS: ₹0.77 (vs ₹0.84 in 2Q 2024) Second quarter 2025 results: EPS: ₹0.77 (down from ₹0.84 in 2Q 2024). Revenue: ₹180.2m (up 14% from 2Q 2024). Net income: ₹11.5m (down 7.8% from 2Q 2024). Profit margin: 6.4% (down from 7.9% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 17% per year, which means it is well ahead of earnings. Announcement • Oct 31
Chemcrux Enterprises Limited to Report Q2, 2025 Results on Nov 11, 2024 Chemcrux Enterprises Limited announced that they will report Q2, 2025 results on Nov 11, 2024 Valuation Update With 7 Day Price Move • Aug 22
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹241, the stock trades at a trailing P/E ratio of 48.6x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 78% over the past three years. Declared Dividend • Aug 22
Dividend reduced to ₹1.00 Dividend of ₹1.00 is 50% lower than last year. Ex-date: 6th September 2024 Payment date: 13th October 2024 Dividend yield will be 0.4%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (18% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 43% per year over the past 7 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 81% to shift the payout ratio to a potentially unsustainable range, which is more than the 4.9% EPS decline seen over the last 5 years. Announcement • Aug 20
Chemcrux Enterprises Limited Proposes Final Dividend for the Financial Year Ended 31 March 2024 Chemcrux Enterprises Limited announced that at the AGM to be held on 13 September, 2024, proposed to declare a final dividend of INR 1/- (One only) per Equity Share @ 10% on 1,48,08,840 Equity Shares of the Company as recommended by the Board of Directors be and is hereby declared to the Equity Shareholders of the Company whose name appear in the Register of Members on 06th September 2024, out of the profits of the Company for the financial year ended on 31st March 2024. Reported Earnings • Jul 31
First quarter 2025 earnings released: EPS: ₹0.84 (vs ₹1.57 in 1Q 2024) First quarter 2025 results: EPS: ₹0.84 (down from ₹1.57 in 1Q 2024). Revenue: ₹175.0m (down 22% from 1Q 2024). Net income: ₹12.4m (down 47% from 1Q 2024). Profit margin: 7.1% (down from 10% in 1Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Announcement • Jul 30
Chemcrux Enterprises Limited, Annual General Meeting, Sep 13, 2024 Chemcrux Enterprises Limited, Annual General Meeting, Sep 13, 2024, at 14:00 Indian Standard Time. Announcement • Jul 24
Chemcrux Enterprises Limited to Report Q1, 2025 Results on Jul 30, 2024 Chemcrux Enterprises Limited announced that they will report Q1, 2025 results at 12:15 PM, Indian Standard Time on Jul 30, 2024 Buy Or Sell Opportunity • Jun 04
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 25% to ₹214. The fair value is estimated to be ₹270, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.4% over the last 3 years, while earnings per share has been flat. Reported Earnings • May 07
Full year 2024 earnings released: EPS: ₹5.70 (vs ₹9.70 in FY 2023) Full year 2024 results: EPS: ₹5.70 (down from ₹9.70 in FY 2023). Revenue: ₹798.0m (down 16% from FY 2023). Net income: ₹84.4m (down 41% from FY 2023). Profit margin: 11% (down from 15% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 42% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Feb 14
Third quarter 2024 earnings released: EPS: ₹1.80 (vs ₹2.42 in 3Q 2023) Third quarter 2024 results: EPS: ₹1.80 (down from ₹2.42 in 3Q 2023). Revenue: ₹223.7m (up 9.1% from 3Q 2023). Net income: ₹26.6m (down 26% from 3Q 2023). Profit margin: 12% (down from 18% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Feb 14
Third quarter 2024 earnings released: EPS: ₹1.80 (vs ₹2.42 in 3Q 2023) Third quarter 2024 results: EPS: ₹1.80 (down from ₹2.42 in 3Q 2023). Revenue: ₹223.7m (up 9.1% from 3Q 2023). Net income: ₹26.6m (down 26% from 3Q 2023). Profit margin: 12% (down from 18% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Feb 07
Chemcrux Enterprises Limited to Report Q3, 2024 Results on Feb 13, 2024 Chemcrux Enterprises Limited announced that they will report Q3, 2024 results on Feb 13, 2024 Reported Earnings • Nov 10
Second quarter 2024 earnings released: EPS: ₹0.84 (vs ₹2.02 in 2Q 2023) Second quarter 2024 results: EPS: ₹0.84 (down from ₹2.02 in 2Q 2023). Revenue: ₹160.8m (down 42% from 2Q 2023). Net income: ₹12.4m (down 69% from 2Q 2023). Profit margin: 7.7% (down from 14% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Nov 04
Chemcrux Enterprises Limited to Report Q2, 2024 Results on Nov 09, 2023 Chemcrux Enterprises Limited announced that they will report Q2, 2024 results on Nov 09, 2023 Announcement • Sep 02
Chemcrux Enterprises Limited Announces Resignation of Mr. Krutarth Parikh as Chief Financial Officer, Effective 13 September 2023 Chemcrux Enterprises Limited informed that Mr. Krutarth Parikh (Chief Financial Officer) has tendered his resignation from the post of the Chief Financial Officer of the Company vide his resignation letter received dated 1st September 2023 and the same has been considered and accepted with effect from end of business hours of 13 September 2023. Reason for change: There is no other material reason for resignation other than those which is provided in the resignation letter. Upcoming Dividend • Aug 29
Upcoming dividend of ₹2.00 per share at 0.6% yield Eligible shareholders must have bought the stock before 05 September 2023. Payment date: 12 October 2023. Payout ratio is a comfortable 21% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.4%). Lower than average of industry peers (0.8%). Announcement • Aug 19
Chemcrux Enterprises Limited, Annual General Meeting, Sep 12, 2023 Chemcrux Enterprises Limited, Annual General Meeting, Sep 12, 2023, at 14:00 Indian Standard Time. Location: 330, TRIVIA Complex, Natubhai Circle, Racecourse, Vadodara India Agenda: To receive, consider and adopt the audited standalone financial statements of the company for the financial year ended 31st March 2023, together with the reports of the Board of Directors and Auditors thereon; to declare final dividend for the financial year ended 31st March 2023, at the rate of 20% (INR 2/-) per Equity Share; to appoint a director in place of Mr. Girishkumar Shah who retires by rotation and being eligible, offers himself for re-appointment; and to discuss other matters. New Risk • Aug 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹4.59b market cap, or US$55.2m). New Risk • Aug 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹4.59b market cap, or US$55.2m). Announcement • Aug 05
Chemcrux Enterprises Limited Announces Board Changes Chemcrux Enterprises Limited approved the appointment of Mrs. Sidhdhi Girishkumar Shah as an Additional Director (Non-Executive & Non-Independent) with effect from 04th August 2023 subject to regularisation of the appointment by the shareholders of the Company at the up coming Annual General Meeting of the Company. Announced resignation of Mrs. Neela Sanjay Marathe (DIN: 00469204) as Non-Executive Non- Independent director of the Company vide her resignation letter received dated 04th August 2023 due pre-occupation and the same has been considered and accepted by the Board with effect from end of business hours of 04th August 2023. Her resignation would lead to changes in constitution of various Committees of the Board. Announcement • Jul 29
Chemcrux Enterprises Limited to Report Q1, 2024 Results on Aug 04, 2023 Chemcrux Enterprises Limited announced that they will report Q1, 2024 results on Aug 04, 2023 Announcement • May 21
Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2022-23 Chemcrux Enterprises Limited recommended Final Dividend for fiscal year 2022-23 at the rate of 20% (INR 2 per share) on the Equity share of INR 10 each subject to the approval of shareholders in the upcoming Annual General Meeting. Valuation Update With 7 Day Price Move • Apr 11
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₹364, the stock trades at a trailing P/E ratio of 33.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 1,437% over the past three years. Reported Earnings • Feb 15
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: ₹208.1m (down 26% from 3Q 2022). Net income: ₹35.8m (down 25% from 3Q 2022). Profit margin: 17% (in line with 3Q 2022). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 123% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Nov 16
Second quarter 2023 earnings released Second quarter 2023 results: EPS: ₹2.72. Net income: ₹40.3m (up ₹40.3m from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 134% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Sep 08
Upcoming dividend of ₹2.00 per share Eligible shareholders must have bought the stock before 15 September 2022. Payment date: 23 October 2022. Payout ratio is a comfortable 18% but the company is paying out more than the cash it is generating. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.6%). Lower than average of industry peers (0.7%). Announcement • Aug 31
Chemcrux Enterprises Limited, Annual General Meeting, Sep 23, 2022 Chemcrux Enterprises Limited, Annual General Meeting, Sep 23, 2022, at 14:00 Indian Standard Time. Location: 330, TRIVIA Complex Natubhai Circle, Racecourse Vadodara Gujarat India Agenda: To receive, consider, approve and adopt the Audited Standalone Financial Statements of the Company for the financial year ended 31st March 2022, together with the reports of the Board of Directors and Auditors thereon; to receive, consider, approved and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended 31st March 2022, together with the reports of the Auditors thereon; to declare final dividend for the financial year ended 31st March 2022, at the rate of 20% (Rs. 2/-) per Equity Share; to appoint a director in place of Mr. Girishkumar Shah, who retires by rotation and being eligible, offers himself for re-appointment; and to consider other matters. Valuation Update With 7 Day Price Move • Aug 26
Investor sentiment improved over the past week After last week's 27% share price gain to ₹455, the stock trades at a trailing P/E ratio of 40.2x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,456% over the past three years. Valuation Update With 7 Day Price Move • Aug 11
Investor sentiment improved over the past week After last week's 16% share price gain to ₹347, the stock trades at a trailing P/E ratio of 34.4x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 921% over the past three years. Announcement • Aug 07
Chemcrux Enterprises Limited to Report Q1, 2023 Results on Aug 12, 2022 Chemcrux Enterprises Limited announced that they will report Q1, 2023 results on Aug 12, 2022 Valuation Update With 7 Day Price Move • Jun 27
Investor sentiment improved over the past week After last week's 22% share price gain to ₹275, the stock trades at a trailing P/E ratio of 27.3x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 758% over the past three years. Valuation Update With 7 Day Price Move • Jun 07
Investor sentiment improved over the past week After last week's 23% share price gain to ₹232, the stock trades at a trailing P/E ratio of 23x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 665% over the past three years. Reported Earnings • May 26
Full year 2022 earnings released: EPS: ₹10.07 (vs ₹6.03 in FY 2021) Full year 2022 results: EPS: ₹10.07 (up from ₹6.03 in FY 2021). Revenue: ₹952.7m (up 79% from FY 2021). Net income: ₹149.2m (up 67% from FY 2021). Profit margin: 16% (down from 17% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 70% per year, which means it is tracking significantly ahead of earnings growth. Announcement • May 21
Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2021-22 Chemcrux Enterprises Limited recommended Final Dividend for Fiscal Year 2021-22 at the rate of 20 % INR 2/- per share on the Equity share of INR 10/- each subject to the approval of shareholders in the upcoming Annual General Meeting. Announcement • May 14
Chemcrux Enterprises Limited to Report Second Half, 2022 Results on May 20, 2022 Chemcrux Enterprises Limited announced that they will report second half, 2022 results on May 20, 2022 Valuation Update With 7 Day Price Move • May 06
Investor sentiment improved over the past week After last week's 18% share price gain to ₹209, the stock trades at a trailing P/E ratio of 32x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 609% over the past three years. Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improved over the past week After last week's 18% share price gain to ₹174, the stock trades at a trailing P/E ratio of 26.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 533% over the past three years. Valuation Update With 7 Day Price Move • Jan 04
Investor sentiment improved over the past week After last week's 29% share price gain to ₹154, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 625% over the past three years. Announcement • Dec 23
Chemcrux Enterprises Limited (BSE:540395) completed the acquisition of a 50% stake in Kalichem Private Limited. Chemcrux Enterprises Limited (BSE : 540395) agreed to acquire a 50% stake in Kalichem Private Limited on September 8, 2021.
Chemcrux Enterprises Limited (BSE:540395) completed the acquisition of a 50% stake in Kalichem Private Limited on December 22, 2021. Valuation Update With 7 Day Price Move • Sep 01
Investor sentiment improved over the past week After last week's 15% share price gain to ₹466, the stock trades at a trailing P/E ratio of 25.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,231% over the past three years. Valuation Update With 7 Day Price Move • Aug 10
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₹414, the stock trades at a trailing P/E ratio of 22.9x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 1,393% over the past three years. Upcoming Dividend • Aug 06
Upcoming dividend of ₹2.00 per share Eligible shareholders must have bought the stock before 13 August 2021. Payment date: 23 September 2021. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.4%). Lower than average of industry peers (0.7%). Executive Departure • Aug 05
Chief Financial Officer Sushilkumar Tripathi has left the company On the 31st of July, Sushilkumar Tripathi's tenure as Chief Financial Officer ended after 1.8 years in the role. We don't have any record of a personal shareholding under Sushilkumar's name. A total of 2 executives have left over the last 12 months. Reported Earnings • Aug 04
Full year 2021 earnings released: EPS ₹18.10 (vs ₹21.56 in FY 2020) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹533.3m (down 7.2% from FY 2020). Net income: ₹89.3m (down 16% from FY 2020). Profit margin: 17% (down from 19% in FY 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 134% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 22
Investor sentiment improved over the past week After last week's 24% share price gain to ₹357, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 959% over the past three years. Announcement • Apr 07
Chemcrux Enterprises Limited Announces Revocation Order of GPCB for Resumption of Production Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and with reference to earlier intimation dated January 19, 2021 and updates submitted on February 24, 2021 and March 31, 2021 relating to shutdown of production operations of Chemcrux Enterprises Limited at Ankleshwar Plant, it is hereby informed that Gujarat Pollution Control Board (GPCB), has directed to revoke the closure directions vide their letter dated April 5, 2021. In view of the issue of revocation order by GPCB, the production operations will be resumed at the Ankleshwar Plant. Announcement • Mar 06
Chemcrux Enterprises Limited Appoints Dipika Rajpal as Whole Time Company Secretary and Compliance Officer Chemcrux Enterprises Limited announced that at the meeting of board of directors of the company held on 5 March 2021; Mrs. Dipika Rajpal having membership no. A56806 of the Institute of Company Secretaries of India is appointed as the whole time company secretary and compliance officer of the company, effective 5 March 2021. Announcement • Feb 21
Chemcrux Enterprises Limited Announces Resignation of Ekta Kumari as Company Secretary and Compliance Officer Chemcrux Enterprises Limited informed that Mrs. Ekta Kumari has ceased to be the Company Secretary and Compliance Officer of the company with effect from conclusion of business hours of February 20, 2021. Announcement • Jan 20
Chemcrux Enterprises Limited Announces Shutdown of Production Activities at Gujarat Ankleshwar Plant Chemcrux Enterprises Limited announced that vide intimation letter dated January 01, 2021 submitted to Pollution Control Board (GPCB), the company has shutdown production activities at Gujarat Ankleshwar Plant, as a self compliance to the Closure Order of GPCB. Company will make Revocation application after complying all points of GPCB order and shall resume production activities after grant of Revocation Order from GPCB. Valuation Update With 7 Day Price Move • Jan 01
Investor sentiment improved over the past week After last week's 16% share price gain to ₹251, the stock is trading at a trailing P/E ratio of 11.7x, up from the previous P/E ratio of 10.1x. This compares to an average P/E of 18x in the Chemicals industry in India. Total returns to shareholders over the past three years are 654%. Announcement • Sep 12
Chemcrux Enterprises Limited Announces Revocation Order and Reinstatement of Production Operations Chemcrux Enterprises Limited announced the shutdown of production operations at Ankleshwar Plant, it is hereby informed that Gujarat Pollution Control Board (GPCB), has issued the revocation order vide its order 567487. In view of the issue of revocation order by GPCB, the production operations will be reinstated at the Ankleshwar Plant. Announcement • Sep 03
Chemcrux Enterprises Limited Announces Shutdown of Production Activities At Ankleshwar Plant Chemcrux Enterprises Limited announced shutdown of production activities at Ankleshwar Plant, as self compliance to the Closure Order of GPCB. Company has already made Revocation application after complying all points of GPCB shall resume production activities after Revocation order. 
